Zongbo Dai

Zongbo Dai

Auto-generated profile, based on publicly available information

Zongbo Dai

Department of Hepatobiliary Surgery, The First Hospital of China Medical University, Shenyang, 110169, China

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2026 in Materials Today Bio
Verified
Journal Article
Open access
ZDZongbo Dai
Zongbo Dai
XLXuejian Li
Xuejian Li
MJMeiqi Jin
Meiqi Jin
WLWanting Liu
Wanting Liu
XLXiaohang Li
Xiaohang Li
JZJialin Zhang
Jialin Zhang
Effective angiogenesis is crucial for tissue engineering and regenerative medicine. However, current strategies such as growth factor or endothelial cell (EC) delivery often face challenges in inducing stable and efficient vascularization. Inspired by mimicking matrix composition and physical architecture of vascular hyperplastic tissues, we developed a novel composite hydrogel composed of decellularized extracellular matrix from human hepatic cavernous hemangioma (HCH dECM) and gelatin methacryloyl (GelMA) to promote angiogenesis for tissue engineering applications. The HCH dECM/GelMA hydrogel exhibited improved mechanical stability, uniform porosity, and retention of pro-angiogenic basement membrane components, as confirmed by proteomic and biomechanical analyses. In vitro, the hydrogel significantly enhanced the viability, proliferation, migration, and tube formation of human umbilical vein endothelial cells (HUVECs), outperforming Matrigel in key morphological metrics. In a mouse subcutaneous implantation model, the HCH dECM/GelMA hydrogel robustly induced vascularization by recruiting host endothelial cells, as evidenced by increased CD31+ and α-SMA+ areas. Mechanistic investigations revealed that the hydrogel upregulates integrin alpha 9 (ITGA9), activating the FAK–ERK1/2 signaling pathway and enhancing the expression of angiogenic cytokines such as VEGFA. Knockdown of ITGA9 abolished these pro-angiogenic effects, confirming the essential role of the ITGA9–FAK–ERK1/2 axis. This work presents a human-derived, bioactive hydrogel with significant potential for vascular regeneration and clinical translation.

15 April 2026 in Journal of X-Ray Science and Technology
Verified
Journal Article
Closed access
ZCZiran Chen
Ziran Chen
Yang YingjianYang Yingjian
Yang Yingjian
MFMengting Feng
Mengting Feng
JZJie Zheng
Jie Zheng
ZDZongbo Dai
Zongbo Dai
YKYan Kang
Yan Kang
Background: Existing methods for segmenting liver cancer from single-modal medical images fail to effectively leverage potential correlations across modalities. These correlations between the anatomical structures of liver cancer and the liver are also crucial for accurate liver cancer segmentation. These challenges not only limit the performance and scalability of liver cancer segmentation models but also pose significant challenges for researchers seeking to develop multimodal, low-annotation-dependent solutions. Therefore, it is necessary to propose a universal liver cancer segmentation network for abdominal computed tomography (CT) and magnetic resonance (MR) medical images. Method: Based on the above, we propose a two-stage universal liver cancer segmentation network for 3D dual-modality abdominal nuclear medical images using a mixed-label, multi-type training strategy. In stage 1, two CT and MR liver segmentation models are trained to generate liver mask images for CT and MR multimodal abdominal images without liver mask label images, thereby solving the laborious technical problem of liver labeling. In stage 2, a mixed-label strategy is proposed, where a mixed-label pool is constructed from CT and MR liver mask images generated by the aforementioned liver segmentation models, along with liver label images and their corresponding liver cancer label images. Subsequently, a universal liver cancer segmentation model is trained using a mixed-label, multi-type training strategy that fully considers potential correlations among different medical imaging modalities, liver cancer, and the liver. Results: The proposed liver cancer segmentation model, based on Medformer and the proposed mixed-label, multi-type abdominal-image training strategy, performs best, validating the effectiveness of the proposed strategy. Discussion: The proposed two-stage universal liver cancer segmentation network, based on a mixed-label and multi-type training strategy, can effectively segment liver cancer in different 3D dual-modality abdominal CT and MR images, which may become an indispensable quantitative analysis tool for liver cancer in clinical practice.